8th Pay Commission to start talks from April 28, many unions may miss out

The 8th Central Pay Commission has started the consultation process with employee unions and associations, with meetings scheduled to take place in Delhi from April 28 to April 30. However, due to a large number of requests, not all stakeholders will be able to participate in this first round.

In a notice dated April 24, 2026, the Commission said it has received a “large number of requests” for interaction during the three-day window in Delhi.

It added that meetings will be scheduled with the maximum possible number of unions and associations, but some requests may not be accommodated due to time constraints.

MORE MEETINGS PLANNED ACROSS STATES

The Commission has clarified that this is only the beginning of the consultation process. It plans to hold more meetings in Delhi as well as across various states and Union Territories in the coming months.

Stakeholders outside Delhi-NCR have been advised to wait for future schedules, when the Commission will visit their respective regions or nearby locations for interactions.

Earlier, a team of the Commission was also scheduled to visit Dehradun on April 24 as part of its outreach.

As the consultation process gathers pace, discussions around a Rs 72,000 minimum salary have been circulating widely among central government employees.

However, this figure is not part of any official proposal submitted to the Commission.

The Rs 72,000 number is largely based on estimates and projections tied to different fitment factor scenarios being discussed in various reports.

The formal demand currently on record comes from the National Council–Joint Consultative Machinery (NC-JCM), Staff Side.

In its memorandum, the body has proposed a minimum basic pay of Rs 69,000 along with a fitment factor of 3.83.

This remains the only structured submission reported so far as part of the consultation process.

The Pay Commission is currently in the consultation stage, where it gathers feedback from employee groups and other stakeholders.

Final recommendations on salaries, allowances and fitment factors will be made only after these discussions are completed.

For now, employees are advised to rely on official updates rather than circulating figures, as the process is still at an early stage.

Latest

Cohance Lifesciences hits 20% upper circuit: Why the stock rising today?

Cohance Lifesciences jumped 20% after appointing former Cipla CEO Umang Vohra. Investors are betting his leadership can accelerate growth and transform the comp

Decoding the Sun Pharma $11.75 billion deal: Why the pharma stock jumped 7% today?

The stock was trading around Rs 1,739.70 as of 9:46 am, up over 7%, after touching a high of Rs 1,741.85 during the session, reflecting strong investor interest

Paytm shares tumble 6% today: Is this dip a buying chance for investors?

Paytm shares fell 6% today. Is this panic-driven weakness, or a smart chance for investors to buy into the fintech stock at lower levels now?

Sun Pharma shares jump over 5% after $11.75 billion Organon deal

Sun Pharma has agreed to buy Organon in an all-cash $11.75 billion deal, including debt. The takeover expands its reach in women's health and marks a sharper gl

Sensex, Nifty jump nearly 1% in early trade: Sun Pharma up 5%

The S&P BSE Sensex was up by 523.17 points to 77,187.38, while the NSE Nifty50 jumped 158.35 points to 24,056.30 as of 9:22 am. 

Topics

Sam Altman says Codex is causing major FOMO so he changing his sleep schedule

Sam Altman says GPT-5.5 in Codex is so good he’s cutting sleep. He has said due to AI he has switched to polyphasic sleep — a schedule involving multiple sh

Cohance Lifesciences hits 20% upper circuit: Why the stock rising today?

Cohance Lifesciences jumped 20% after appointing former Cipla CEO Umang Vohra. Investors are betting his leadership can accelerate growth and transform the comp

30 students suspended at Hansraj College over fest chaos, DUSU calls it undemocratic

Hansraj College has placed around 30 students, including four elected union office-bearers, under interim suspension over alleged misconduct tied to its annual

Decoding the Sun Pharma $11.75 billion deal: Why the pharma stock jumped 7% today?

The stock was trading around Rs 1,739.70 as of 9:46 am, up over 7%, after touching a high of Rs 1,741.85 during the session, reflecting strong investor interest

Paytm shares tumble 6% today: Is this dip a buying chance for investors?

Paytm shares fell 6% today. Is this panic-driven weakness, or a smart chance for investors to buy into the fintech stock at lower levels now?

Sun Pharma shares jump over 5% after $11.75 billion Organon deal

Sun Pharma has agreed to buy Organon in an all-cash $11.75 billion deal, including debt. The takeover expands its reach in women's health and marks a sharper gl

Sensex, Nifty jump nearly 1% in early trade: Sun Pharma up 5%

The S&P BSE Sensex was up by 523.17 points to 77,187.38, while the NSE Nifty50 jumped 158.35 points to 24,056.30 as of 9:22 am. 

Sensex, Nifty opening: Will stock market rise or fall today?

Benchmark indices are set to open higher on Monday after a three-session slide, with GIFT Nifty pointing to a near 1% gap-up start. Elevated crude prices, conti
spot_img

Related Articles

Popular Categories

spot_imgspot_img